Emerald Advisers’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-894,144
Closed -$12.2M 366
2020
Q2
$12.2M Sell
894,144
-5,626
-0.6% -$77.5K 0.53% 71
2020
Q1
$11.7M Sell
899,770
-97
-0% -$1.73K 0.68% 57
2019
Q4
$18.1M Sell
899,867
-2,600
-0.3% -$63.1K 0.77% 51
2019
Q3
$23.2M Buy
902,467
+240,354
+36% +$5.89M 1.09% 31
2019
Q2
$16.1M Buy
662,113
+567,038
+596% +$12.4M 0.65% 64
2019
Q1
$1.9M Buy
+95,075
New +$1.73M 0.08% 130

Other funds holding RDUS

Emerald Advisers's RDUS Position: Q3 2020 in Review

Emerald Advisers sold out of Radius Health, Inc. (RDUS) in Q3 2020, closing a stake of 894,144 shares — an estimated $12.2M sold.

Emerald Advisers first reported a position in RDUS in Q1 2019 and held it in 6 quarters. The position peaked at $23.2M in Q3 2019. 132 funds tracked by Wall St. Rank hold RDUS as of Q3 2020.

  • Emerald Advisers reported no remaining Radius Health, Inc. position as of Q3 2020 after selling out during the quarter.
  • Emerald Advisers sold 894,144 Radius Health, Inc. shares in Q3 2020, an estimated $12.2M.
  • Emerald Advisers first reported a position in Radius Health, Inc. in Q1 2019 and held it in 6 quarters.
  • Emerald Advisers's Radius Health, Inc. position peaked at $23.2M in Q3 2019.
  • 132 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2020.

Based on Emerald Advisers's 13F filing for Q3 2020, filed 28 Oct 2020.